Holen Sie sich die Stockscreener-App
0.1423
7.11%
-0.0109
Vorhandelsmarkt:
.15
0.0077
+5.41%
Silexion Therapeutics Corp Aktie (SLXN) Neueste Nachrichten
Form DEF 14A SILEXION THERAPEUTICS CORP For: 12 October By Investing.com - Investing.com Nigeria
Form DEF 14A SILEXION THERAPEUTICS CORP For: 12 October By Investing.com - Investing.com UK
Silexion Therapeutics Announces First Patient Successfully Dosed in Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer - GlobeNewswire Inc.
Silexion cuts warrant price to raise $840K in cash infusion - Dealroom
Silexion Therapeutics Announces Warrant Inducement Financing Deal - The Globe and Mail
Silexion Therapeutics Announces Warrant Inducement Financing Deal - TipRanks
Form 8K Silexion Therapeutics Corp For: 29 September By Investing.com - Investing.com UK
A cash deal at Silexion (SLXN) comes with rights to buy up to 6.4 million more shares. - Stock Titan
Silexion raises $837,000 through warrant exercise at reduced price - Investing.com
Silexion raises $837,000 through warrant exercise at reduced price By Investing.com - Investing.com Canada
Silexion Therapeutics Announces Exercise of Warrants - GlobeNewswire
Silexion Therapeutics Corp. Announces Immediate Exercise of Series E Warrants and Issuance of New Warrants in $837,366 Financing - Quiver Quantitative
Form PRE 14A SILEXION THERAPEUTICS CORP For: 26 September By Investing.com - Investing.com Canada
Silexion Therapeutics Receives Nasdaq Bid Price Deficiency Notice - The Globe and Mail
Silexion Therapeutics Shareholders Reject Capital Structure Changes - The Globe and Mail
Form PRE 14A SILEXION THERAPEUTICS CORP For: 26 September By Investing.com - Investing.com UK
Silexion Therapeutics Notified of Nasdaq Bid Price Deficiency, Trading Continues Unaffected - Kalkine Media
Silexion Therapeutics Receives Nasdaq Bid Price Deficiency Notice - TipRanks
Why Is the Market Watching Silexion Therapeutics (SLXN)? - kalkinemedia.com
Biotech Pre-Market Movers: TNON, AEON Surge; COO, CDT Slide - RTTNews
Silexion Therapeutics to Participate in September 2026 Industry and Investor Conferences - GlobeNewswire
After Moderna’s $44B Oncology Win, Silexion’s Pancreatic Cancer Treatment is Worth Exploring (NASDAQ: SLXN) - TipRanks
Silexion (SLXNW) Range: Finishes Nearly Flat at $0.01 in Latest Trading; Next Test - vinanet.vn
Silexion Therapeutics Receives Nasdaq Delisting Notice, Plans Appeal - TipRanks
Silexion Therapeutics Received Notice of Delisting - TradingView
Silexion Therapeutics Executes Reverse Share Split Amid Strain - The Globe and Mail
Silexion Therapeutics Closes Public Offering and Strengthens Equity - The Globe and Mail
Silexion Therapeutics (SLXN) seeks huge share boost and reverse split to stay on Nasdaq - Stock Titan
Silexion Q2 EPS $(5.17) misses $(2.12) estimate; loss widens - scanx.trade
Silexion Therapeutics Raises $35 Million in August Public Offering - Minichart
Silexion Therapeutics Corp 2Q 2026: Net loss $3.55M, EPS $(12.41) — 10-Q Summary - TradingView
Silexion Initiates Phase 2/3 Pancreatic Cancer Trial on July 29 - Minichart
Silexion Therapeutics Reports Second Quarter 2026 Financial Results And Provides Business Update - TradingView
Silexion Reports $3.6 Million Second-Quarter Net Loss as SIL204 Trial Starts - Moomoo
Silexion Reports $3.6 Million Second-Quarter Net Loss as SIL204 Trial Starts - Quiver Quantitative
Silexion Therapeutics reports Q2 2026: $3.6M Q2 net loss, $2.2M cash at June 30 - TradingView
Silexion Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update - The Manila Times
Press Release: Silexion Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update - Moomoo
Silexion Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update - The Manila Times
Silexion Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update - GlobeNewswire
Silexion Completes 1-for-10 Reverse Share Split - Minichart
Form 8K Silexion Therapeutics Corp For: 13 August By Investing.com - Investing.com Nigeria
Silexion Therapeutics Executes Reverse Share Split Amid Strain - TipRanks
Form 8K Silexion Therapeutics Corp For: 13 August By Investing.com - Investing.com India
Silexion Therapeutics Closes Public Offering and Strengthens Equity - TipRanks
Form 8K Silexion Therapeutics Corp For: 13 August By Investing.com - Investing.com Canada
Silexion Therapeutics Corp (SLXN) investors report 0% holding but retain warrants - Stock Titan
Form 8K Silexion Therapeutics Corp For: 13 August By Investing.com - Investing.com UK
Silexion Therapeutics Raises $2.5 Million in Best-Efforts Equity Offering With H.C. Wainwright - TradingView
Silexion Therapeutics Corp SEC Filing (Aug 12, 2026) - Stock Titan
2.14%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):